CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-06 | Hartzel William SVP, Bioservices | Returned to the company | −5,771 | $10.92 | $63K | 97,311 |
| 2026-02-06 | Hartzel William SVP, Bioservices | Shares withheld for taxes | −630 | $10.92 | $7K | 96,681 |
| 2026-02-06 | Williams Paul Anthony SVP, Products Business | Returned to the company | −8,655 | $10.92 | $95K | 77,216 |
| 2026-02-06 | Williams Paul Anthony SVP, Products Business | Shares withheld for taxes | −1,022 | $10.92 | $11K | 76,194 |
| 2026-02-06 | Glessner Coleen EVP, Quality & Ethics, and CPL | Returned to the company | −28,847 | $10.92 | $315K | 115,472 |
| 2026-02-06 | Glessner Coleen EVP, Quality & Ethics, and CPL | Shares withheld for taxes | −2,852 | $10.92 | $31K | 112,620 |
| 2026-02-06 | LINDAHL RICHARD S EVP, Chief Financial Officer | Returned to the company | −46,155 | $10.92 | $504K | 245,342 |
| 2026-02-06 | LINDAHL RICHARD S EVP, Chief Financial Officer | Shares withheld for taxes | −5,642 | $10.92 | $62K | 239,700 |
| 2025-12-14 | Lowry Simon C SVP, R&D, CMO | Shares withheld for taxes | −3,543 | $11.41 | $40K | 88,439 |
| 2025-12-05 | Richard Ronald Director | Sale | −7,100 | $12.11 | $86K | 98,417 |
| 2025-12-05 | Richard Ronald Director | Option exercise | +25,748 | $5.02 | $129K | 124,165 |
| 2025-12-05 | Richard Ronald Director | Shares withheld for taxes | −10,864 | $11.90 | $129K | 113,301 |
| 2025-12-05 | Richard Ronald Director | Sale | −14,884 | $11.90 | $177K | 98,417 |
| 2025-12-05 | Richard Ronald Director | Option exercise · Stock Option (Right to Buy) | −25,748 | 0 | ||
| 2025-11-11 | Hartzel William SVP, Bioservices | Shares withheld for taxes | −610 | $10.88 | $7K | 103,082 |
| 2025-11-10 | DeGolyer Donald W Director | Sale | −17,801 | $10.54 | $188K | 119,858 |
| 2025-11-07 | Dayal Sujata Tyagi Director | Sale | −8,552 | $10.00 | $86K | 88,980 |
| 2025-10-15 | LINDAHL RICHARD S EVP, Chief Financial Officer | Shares withheld for taxes | −4,995 | $9.60 | $48K | 291,497 |
| 2025-10-07 | Glessner Coleen EVP, Quality & Ethics, and CPL | Sale | −30,608 | $10.00 | $306K | 144,319 |
| 2025-08-15 | Zoon Kathryn C Director | Sale 10b5-1 | −7,086 | $8.87 | $63K | 71,799 |
Page 4 of 17 · 330 trades